InVivoMAb anti-mouse PD-1 (CD279), 25 mg and 1 more item
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0470494
- Awardee
- Bio X Cell
- Contracting organization
- University of Virginia
- Cumulative value
- $2,891
About this award
The University of Virginia awarded a contract to Bio X Cell on August 19, 2026, for the procurement of specialized immunological reagents. The contract, identified as A207_PO-0470494, carries a cumulative value of $2,890.65 and is being delivered to Ji Song. The award was made in Virginia and encompasses two distinct line items for research-grade biological products.
The deliverables consist of InVivoMAb anti-mouse programmed death receptor 1 (PD-1/CD279) at 25 milligrams, valued at $1,644.65, and InVivoMAb recombinant Flt3-ligand immunoglobulin fusion protein (human/human) at 5 milligrams, valued at $1,246.00. These monoclonal antibody and fusion protein products are commonly utilized in immunological research applications. Both items are being supplied as single units to support the University of Virginia's research operations.
Line items
| Item | Total |
|---|---|
| InVivoMAb anti-mouse PD-1 (CD279), 25 mg | $1,644.65 |
| InVivoMAb recombinant Flt-3L-Ig (hum/hum), 5 mg | $1,246.00 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0470494?
Contract A207_PO-0470494 was awarded to Bio X Cell by University of Virginia on August 19, 2026.
How much is contract A207_PO-0470494 worth?
Its cumulative value is $2,891.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award